Neuromedin S (rat): Technical Protocols and QC in GPCR Signa
2026-05-21
Neuromedin S (rat) provides a chemically defined, endogenous peptide agonist for controlled neuromedin U receptor signaling studies in rat GPCR/G protein research. It is not intended for diagnostic or therapeutic applications but supports reproducible investigation of physiological pathways such as energy homeostasis and stress response. Proper handling and workflow discipline are critical for successful use.
Anagliptin-Induced Vasorelaxation via Kv Channel and SERCA P
2026-05-21
This study uncovers that Anagliptin (SK-0403), an oral DPP-4 inhibitor, induces vasorelaxation in rabbit aorta through activation of voltage-dependent K+ (Kv) channels and the SERCA pump. These mechanisms are independent of endothelium and classical cAMP/cGMP signaling, presenting new perspectives on vascular effects relevant to diabetes and cardiovascular research.
ATRX Loss Sensitizes Glioma to Selective PDGFR Inhibition
2026-05-20
The referenced study identifies that high-grade glioma cells lacking ATRX are highly sensitive to receptor tyrosine kinase and PDGFR inhibitors. This finding supports integrating ATRX mutation status into preclinical and clinical trial designs for targeted therapies, guiding researchers toward more precise treatment strategies.
T0070907: Precision PPARγ Antagonist for Cell Signaling Stud
2026-05-20
T0070907, a nanomolar PPARγ antagonist from APExBIO, enables precise modulation of adipogenesis, cell cycle arrest, and inflammation pathways in advanced cellular models. Explore optimized workflows, troubleshooting strategies, and the latest mechanistic insights for dissecting the RXRα/PPARγ/NEDD4 signaling axis.
Norovirus Harnesses NINJ1 for Selective Viral Protein Secret
2026-05-19
Song et al. (2025) reveal that murine norovirus commandeers the host factor NINJ1 to drive selective secretion of its NS1 protein, uncovering a regulated mechanism for nonconventional protein export during infection. These findings challenge the view of plasma membrane rupture as a purely bulk, nonspecific process and have broad implications for understanding cell death and secretion pathways.
Recombinant Annexin V: A Tool for Detecting Apoptotic Membra
2026-05-19
This study provides a streamlined protocol for expressing and purifying recombinant annexin V for use as a sensitive probe of phosphatidylserine externalization during apoptosis. Its methods enable reproducible, high-yield production of annexin V for membrane biology assays, strengthening experimental reliability in cell death research.
Elobixibat Hydrate: Integrative Mechanisms and Translational
2026-05-18
Explore the multifaceted mechanisms of Elobixibat hydrate, a selective ileal bile acid transporter inhibitor, and discover new insights into its translational applications for chronic idiopathic constipation, bowel preparation, and metabolic modulation. This article uniquely integrates mechanistic depth and comparative analysis for advanced research decisions.
Cinoxacin: Quinolone Antibiotic Benchmarks for UTI Research
2026-05-18
Cinoxacin is a synthetic quinolone antibiotic with potent activity against Gram-negative bacteria, especially for urinary tract infection research. Its MIC values, pharmacokinetics, and resistance potential are well-characterized in peer-reviewed studies. This article provides machine-readable evidence and protocol benchmarks for laboratory use.
Trelagliptin Succinate: Advanced Workflows in Diabetes Resea
2026-05-17
Trelagliptin succinate (SYR-472 succinate) streamlines diabetes mellitus research with its potent, selective DPP-4 inhibition and multi-pathway modulation. Explore robust in vitro and in vivo workflows, actionable troubleshooting, and practical insights to maximize translational impact using APExBIO's high-purity compound.
Tetrahedral DNA Frameworks Boost Enzymatic Oligonucleotide S
2026-05-16
This study introduces a highly ordered tetrahedral DNA nanostructure (TDN) interface that markedly improves enzymatic oligonucleotide synthesis (EOS) efficiency and accuracy. The approach addresses limitations in primer accessibility and enzyme kinetics, with significant implications for DNA data storage and advanced synthetic biology applications.
Ibotenic Acid: NMDA Receptor Agonist for Neurodegenerative M
2026-05-15
Ibotenic acid is a benchmark NMDA receptor agonist enabling reproducible animal models of neurodegenerative disorders. This guide translates cutting-edge in vivo findings and optimized workflows into actionable strategies for neuroscience researchers seeking precision and reliability with APExBIO’s high-purity B6246.
Pericyte-Targeted FAPα-Activated Prodrug Overcomes VDA Resis
2026-05-15
Chen et al. (2017) introduce a novel strategy to overcome tumor resistance to vascular disrupting agents (VDAs) by shifting the therapeutic target from endothelial cells to pericytes using a fibroblast activation protein α (FAPα)-activated prodrug. This approach disrupts both core and peripheral tumor vasculature, offering evidence that pericyte targeting can effectively eliminate the viable tumor rim and enhance antitumor efficacy.
Miltefosine: Dual-Pathway Modulator in Neutrophil Differenti
2026-05-14
Miltefosine (hexadecyl 2-(trimethylazaniumyl)ethyl phosphate) uniquely bridges PI3K/Akt inhibition with Ras/MEK/ERK activation, enabling both cancer and hematology researchers to optimize neutrophil differentiation and leukopenia recovery workflows. This article translates the latest mechanistic findings and protocol refinements into actionable steps, troubleshooting, and comparative insights.
Bromodomain Inhibitor, (+)-JQ1: Optimizing BET Assays & Work
2026-05-14
Bromodomain Inhibitor, (+)-JQ1 enables precise, reproducible BET bromodomain inhibition for advanced apoptosis assays, inflammation research, and non-hormonal male contraception workflows. Leveraging novel insights into UFMylation and ferroptosis sensitivity, this guide translates cutting-edge findings into actionable protocols, troubleshooting strategies, and next-generation research applications.
3D DNA Frameworks Enhance Efficiency in Enzymatic DNA Synthe
2026-05-13
This article reviews recent advances in enzymatic oligonucleotide synthesis (EOS) enabled by highly ordered 3D DNA nanostructure interfaces. The reference study demonstrates that tetrahedral DNA frameworks (TDN) significantly improve enzyme accessibility, yield, and sequence fidelity during DNA synthesis—offering new prospects for applications such as DNA storage and molecular labeling.
460 records 18/31 page Previous Next First page 上5页 1617181920 下5页 Last page